Diabetic Gastroparesis Clinical Trials

Gastroparesis creates feelings of bloating, nausea, vomiting and pain. Wake Research Associates is enrolling volunteers with idiopathic or diabetic gastroparesis in a study testing an investigational medication.

A clinical trial is being conducted to assess the safety and efficacy of a treatment for patients with diabetic and non-diabetic gastroparesis.

0099 : A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis.

METO-IN-004 : A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men with symptoms associated with Diabetic Gastroparesis.

METO-IN-003 : A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women with symptoms associated with Diabetic Gastroparesis.

Diabetic Gastroparesis creates feelings of bloating, nausea, vomiting and pain.

A phase 2, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of RM -131 administered to patients with diabetic gastroparesis

A research study is evaluating an investigational drug for Diabetic Gastroparesis.

Now enrolling for a diabetic gastroparesis research study. For more information contact: Clinical Trials of Texas, Inc. 210-949-0122.

A research study is evaluating an investigational medication for the symptoms of Diabetic Gastroparesis.